LONDON--(BUSINESS WIRE)--Technavio has been monitoring the osteoarthritis therapeutics market and it is poised to grow by USD 2.99 billion during 2020-2024, progressing at a CAGR of almost 9% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment.
Click & Get a Free sample report in minutes
Impact of COVID-19
The COVID-19 pandemic continues to transform the growth of various industries, however, the immediate impact of the outbreak is varied. While a few industries will register a drop in demand, numerous others will continue to remain unscathed and show promising growth opportunities. COVID-19 will have At Par impact on the osteoarthritis therapeutics market. The market growth in 2020 is likely to increase compared to market growth in 2019.
Frequently Asked Questions:
Based on the segmentation by the product, which is the leading segment in the market?
Analgesics and NSAIDs are the leading segments in the market.
What are the major trends in the market?
The availability of guidelines for disease management is the major trend in the market.
At what rate is the market projected to grow?
The market is projected to accelerate at a CAGR of almost 9%.
Who are the top players in the market?
Abbott Laboratories, Anika Therapeutics Inc., Bayer AG, F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Johnson & Johnson, Novartis AG, Pfizer Inc., Sanofi, and Zimmer Biomet Holdings Inc. are the top players in the market.
What are the key market drivers and challenges?
The market is driven by the increasing incidence of osteoarthritis. However, the high cost of treatment will challenge growth.
How big is the North American market?
32% of the market’s growth will originate from North America during the forecast period.
Related Reports on Health Care Include:
Global Rabies Treatment Market- The rabies treatment market is segmented by product (vaccines and RIG), application (pre-exposure vaccination and post-exposure prophylaxis), route of administration (intradermal route of administration, intramuscular route of administration, and oral route of administration), geography (Asia, Europe, North America, and ROW), and key vendors. Click Here to Get an Exclusive Free Sample Report
Global Celiac Diseases Drugs Market- The celiac disease drug market is segmented by therapy type (first line of treatment and second line of treatment) and geography (Asia, Europe, North America, and ROW). Click Here to Get an Exclusive Free Sample Report
Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.
The market is fragmented, and the degree of fragmentation will accelerate during the forecast period. Abbott Laboratories, Anika Therapeutics Inc., Bayer AG, F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, Johnson & Johnson, Novartis AG, Pfizer Inc., Sanofi, and Zimmer Biomet Holdings Inc. are some of the major market participants. Although the increasing incidence of osteoarthritis will offer immense growth opportunities, high cost of treatment is likely to pose a challenge for the market vendors. In a bid to help players strengthen their market foothold, this osteoarthritis therapeutics market forecast report provides a detailed analysis of the leading market vendors. The report also empowers industry honchos with information on the competitive landscape and insights into the different product offerings offered by various companies.
Technavio's custom research reports offer detailed insights on the impact of COVID-19 at an industry level, a regional level, and subsequent supply chain operations. This customized report will also help clients keep up with new product launches in direct & indirect COVID-19 related markets, upcoming vaccines and pipeline analysis, and significant developments in vendor operations and government regulations.
Osteoarthritis Therapeutics Market 2020-2024: Segmentation
The osteoarthritis therapeutics market is segmented as below:
- Analgesics & NSAIDs
- North America
To learn more about the global trends impacting the future of market research, download a free sample: https://www.technavio.com/talk-to-us?report=IRTNTR43212
Osteoarthritis Therapeutics Market 2020-2024: Scope
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources. The osteoarthritis therapeutics market report covers the following areas:
- Osteoarthritis Therapeutics Market Size
- Osteoarthritis Therapeutics Market Trends
- Osteoarthritis Therapeutics Market Industry Analysis
This study identifies the availability of guidelines for disease management as one of the prime reasons driving the osteoarthritis therapeutics market growth during the next few years.
Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Technavio’s in-depth research has direct and indirect COVID-19 impacted market research reports.
Register for a free trial today and gain instant access to 17,000+ market research reports.
Technavio's SUBSCRIPTION platform
Osteoarthritis Therapeutics Market 2020-2024: Key Highlights
- CAGR of the market during the forecast period 2020-2024
- Detailed information on factors that will assist osteoarthritis therapeutics market growth during the next five years
- Estimation of the osteoarthritis therapeutics market size and its contribution to the parent market
- Predictions on upcoming trends and changes in consumer behavior
- The growth of the osteoarthritis therapeutics market
- Analysis of the market’s competitive landscape and detailed information on vendors
- Comprehensive details of factors that will challenge the growth of osteoarthritis therapeutics market vendors
Table of Contents:
- Market Overview
- Market ecosystem
- Value chain analysis
- Market definition
- Market segment analysis
- Market size 2019
- Market outlook: Forecast for 2019 - 2024
Five Forces Analysis
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
Market Segmentation by Product
- Market segments
- Comparison by Product
- Analgesics and NSAIDs - Market size and forecast 2019-2024
- Corticosteriods - Market size and forecast 2019-2024
- Viscosupplements - Market size and forecast 2019-2024
- Others - Market size and forecast 2019-2024
- Market opportunity by Product
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2019-2024
- Europe - Market size and forecast 2019-2024
- Asia - Market size and forecast 2019-2024
- ROW - Market size and forecast 2019-2024
- Key leading countries
- Market opportunity by geography
Drivers, Challenges, and Trends
- Market drivers
- Market challenges
- Market trends
- Landscape disruption
- Vendors covered
- Market positioning of vendors
- Abbott Laboratories
- Anika Therapeutics Inc.
- Bayer AG
- F. Hoffmann-La Roche Ltd.
- GlaxoSmithKline Plc
- Johnson & Johnson
- Novartis AG
- Pfizer Inc.
- Zimmer Biomet Holdings Inc.
- Scope of the report
- Currency conversion rates for US$
- Research methodology
List of abbreviations
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.